Clinical Relevance of Lateral Pelvic Lymph Node Dissection for Enlarged Lateral Nodes in Locally Advanced Low Rectal Cancer without Preoperative Treatment-Reference-Cited by-同舟云学术

Clinical Relevance of Lateral Pelvic Lymph Node Dissection for Enlarged Lateral Nodes in Locally Advanced Low Rectal Cancer without Preoperative Treatment

Published:2023-04-25 Issue:2 Volume:7 Page:126-134
ISSN:2432-3853
Container-title:Journal of the Anus, Rectum and Colon
language:en
Short-container-title:J Anus Rectum Colon

Author:

Ouchi Akira¹,Komori Koji¹,Kinoshita Takashi¹,Sato Yusuke¹,Ito Seiji¹,Abe Tetsuya¹,Shimizu Yasuhiro¹

Affiliation:

1. Department of Gastroenterological Surgery, Aichi Cancer Center Hospital

Publisher

The Japan Society of Coloproctology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jarc/7/2/7_2022-064/_pdf

Reference27 articles.

1. 1. Europe WHOROF. World Cancer Report 2019 December 2020.

2. 2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001 Aug; 345 (9): 638-46.

3. 3. Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan; 22 (1): 29-42.

4. 4. Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021 May; 22 (5): 702-15.

5. 5. Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (Chemo) radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol. 2019 Jan; 37 (1): 33-43.